Monday, April 18, 2011

Comment on the recent GAO criticism of the FDA

A couple of days ago I reported (here) that Federal analysts testified in Cogress that the FDA is failing to protect the public from defective medical devices by allowing them on the market with little testing through an industry-exploited fast-track approval program. The Drug and Device Blog has posted a short reply to the report here.

No comments: